Nu-Med Plus (NUMD) Net Income towards Common Stockholders (2012 - 2025)
Nu-Med Plus recorded quarterly Net Income towards Common Stockholders of -$12618.0 in Q4 2025, down 5.45% quarter-over-quarter from -$11966.0 in Q3 2025, and down 19.55% year-over-year from -$15683.3 in Q4 2024.
Nu-Med Plus' Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at -$12618.0 for Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders fell 19.55% year-over-year to -$12618.0; the TTM figure through Dec 2025 stood at -$56182.0 (up 17.8% YoY), while the FY2025 annual figure was -$56182.0, up 17.8% from the prior year.
- Net Income towards Common Stockholders came in at -$12618.0 for Q4 2025 at Nu-Med Plus, down from -$11966.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $42606.0 in Q4 2022 to a low of -$356748.0 in Q1 2021.
- A 5-year average of -$60664.0 and a median of -$23073.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders soared 137.93% in 2022 and slumped 232.84% in 2023, its largest moves.
- Nu-Med Plus' Net Income towards Common Stockholders stood at -$112341.0 in 2021, then jumped by 137.93% to $42606.0 in 2022, then plunged by 232.84% to -$56596.0 in 2023, then jumped by 81.35% to -$10555.0 in 2024, then retreated by 19.55% to -$12618.0 in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$12618.0, -$11966.0, and -$11665.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nu-Med Plus | - | - | - | -12,618.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,618.00 |
| Sep 30, 2025 | -11,966.00 |
| Jun 30, 2025 | -11,665.00 |
| Mar 31, 2025 | -19,933.00 |
| Dec 31, 2024 | -10,555.00 |
| Sep 30, 2024 | -18,677.00 |
| Jun 30, 2024 | -17,287.00 |
| Mar 31, 2024 | -21,826.00 |
| Dec 31, 2023 | -56,596.00 |
| Sep 30, 2023 | -16,406.00 |
| Jun 30, 2023 | -24,320.00 |
| Mar 31, 2023 | -28,204.00 |
| Dec 31, 2022 | 42,606.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -59,653.00 |
| Dec 31, 2021 | -112,341.00 |
| Sep 30, 2021 | -118,366.00 |
| Jun 30, 2021 | -242,606.00 |
| Mar 31, 2021 | -356,748.00 |
| Dec 31, 2020 | -507,696.00 |
| Sep 30, 2020 | -453,824.00 |
| Jun 30, 2020 | -908,467.00 |
| Mar 31, 2020 | -153,334.00 |
| Dec 31, 2019 | -209,881.00 |
| Sep 30, 2019 | -150,576.00 |
| Jun 30, 2019 | -248,184.00 |
| Mar 31, 2019 | -428,195.00 |
| Dec 31, 2018 | -350,509.00 |
| Sep 30, 2018 | -517,290.00 |
| Jun 30, 2018 | -163,871.00 |
| Mar 31, 2018 | -137,570.00 |
| Dec 31, 2017 | 3.90 Mn |
| Sep 30, 2017 | -132,521.00 |
| Jun 30, 2017 | -106,553.00 |
| Mar 31, 2017 | -65,823.00 |
| Dec 31, 2016 | 938,870.00 |
| Sep 30, 2016 | -690,254.00 |
| Jun 30, 2016 | -172,446.00 |
| Mar 31, 2016 | -60,143.00 |
| Dec 31, 2015 | 815,349.00 |
| Sep 30, 2015 | -299,358.00 |
| Jun 30, 2015 | -385,324.00 |
| Mar 31, 2015 | -114,747.00 |
| Dec 31, 2014 | -525,878.00 |
| Sep 30, 2014 | -234,924.00 |
| Jun 30, 2014 | -194,336.00 |
| Mar 31, 2014 | -144,347.00 |
| Sep 30, 2013 | -33,395.00 |
| Jun 30, 2013 | -31,139.00 |
| Mar 31, 2013 | -78,374.00 |
| Dec 31, 2012 | -266,403.00 |
| Mar 31, 2012 | -19,534.00 |